Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Save on this medicine
Same active ingredient — pay up to 15% less
These brands contain the same active ingredient (Rizatriptan Benzoate). Same strength and form. Confirm the switch with your doctor or pharmacist.
Indications & Uses
Rizamig is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Dosage Single doses of 5 or 10 mg of Rizatriptan Tablets is indicated for the acute treatment of migraines in adults. Doses should be separated by at least 2 hours; no more than 30 mg should be taken in any 24-hour period.Dosage adjustment for special case: The choice of dose should therefore be made on an individual basis,weighing the possible benefit of the 10-mg dose with the potential risk for increased adverse events. The safety of treating, on average, more than four headaches in a 30-day period has not been established. Patients receiving propranolol: In patients receiving propranolol, the 5-mg dose of Rizatriptan should be used, up to a maximum of 3 doses in any 24-hour period.
Side Effects
Cardiac events are rare and most have been reported in patients with risk factors predictive of CAD. Cardiac events reported have included coronary artery vasospasm, transient myocardial ischemia, myocardial infarction, ventricular tachycardia, and ventricular fibrillation. In general, chills, heat sensitivity, facial edema, hangover effect, and abdominal distention were reported infrequently. Rarely fever, orthostatic effects, syncope and edema/swelling were reported.
Cautions & Contraindications
Warnings & Precautions
Rizamig should only be used where a clear diagnosis of migraine has been established. Rizamig should not be given to patients with documented ischemic or vasospastic coronary artery disease. Drugs in this class may cause coronary artery vasospasm, patients who experience signs or symptoms suggestive of angina following dosing should be evaluated for the presence of CAD or a predisposition to Prinzmetal’s variant angina before receiving additional doses of medication, and should be monitored electrocardiographically. Rizamig should be used with caution in patients with moderate hepatic insufficiency. For a given attack, if a patient has no response to the first dose of rizatriptan, the diagnosis of migraine should be reconsidered before administration of a second dose.
Contraindications
Rizatriptan Benzoate should not be given to patients with ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm, including Prinzmetal’s variant angina, or other significant underlying cardiovascular disease.As Rizatriptan Benzoate may increase blood pressure, it should not be given to patients with uncontrolled hypertension. Rizatriptan Benzoate is contraindicated in patients who are hypersensitive to rizatriptan or any of its inactive ingredients.